ARTAssistant

by Manteia Technologies Co., Ltd.  · Based in China → — AI-Powered Software for Precision Adaptive Radiation Therapy
Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

ARTAssistant by Manteia Technologies Co., Ltd. is a specialized software application designed to process and analyze radiological images for radiation therapy planning and delivery. Built for radiation oncology departments, cancer centers, and clinical medical physicists, the platform supports clinicians in managing complex imaging data to facilitate targeted radiation treatments.

The software integrates into the clinical radiation therapy workflow by assisting with the analysis of planning imaging. Key capabilities and workflow features include:

  • Radiological Image Processing: Streamlines the preparation and analysis of multi-modality imaging data specifically for radiotherapy applications.
  • Treatment Planning Support: Helps clinicians identify and evaluate target areas to assist in planning precise external beam irradiation.
  • Adaptive Therapy Integration: Provides data processing capabilities that support clinicians in evaluating and adapting treatment plans based on anatomical changes over time.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Image processing for online adaptive radiotherapy
  • Automatic rigid and deformable image registration
  • Image conversion (synthetic CT generation from CBCT or MR)
  • Image contouring (manual contouring of organs-at-risk with assisted tools)
  • Receive, add/edit/delete, transmit, input/export medical images and DICOM data
  • Patient management
  • Review of processed images
  • Assists in planning and delivering targeted radiation treatment
  • Improves accuracy and effectiveness of radiation therapy

Use Cases

  • Assisting in the implementation of adaptive radiotherapy
  • Designing daily adaptive radiotherapy plans based on processed images
  • Image processing for online adaptive radiation therapy
  • Analyzing imaging data for radiation treatment planning
  • Enhancing workflow efficiency in radiation therapy

What Physicians Need to Know

Key Capabilities
ARTAssistant is part of a comprehensive radiation therapy solution that includes AI-contouring (AccuContour), deep learning powered local training (AccuLearning), next-generation treatment planning (Mozi TPS), and Monte Carlo patient QA and machine QC. It integrates AI and Monte Carlo methods for precision, efficiency, and automation in radiation oncology.
Clinical Utility
The solution aims to enhance treatment accuracy and adaptability in radiation therapy. AccuContour, a component of the suite, is noted for saving significant time for planners and maintaining efficient workflow in the contouring step, with its quality and efficiency recognized by physicians.
Integration Options
ARTAssistant is designed as a vendor-independent and fully interoperable system, allowing seamless integration into existing clinical workflows.
User Experience
Physician testimonials highlight the positive impact on workflow efficiency and the recognized quality of the AI-contouring component, AccuContour.
Implementation Complexity
The system is designed for seamless integration into existing workflows, suggesting a focus on minimizing implementation hurdles.
Physician Tip

Consider leveraging ARTAssistant's AI-contouring capabilities (AccuContour) to significantly reduce planning time and improve workflow efficiency. The vendor-independent nature of the system should facilitate integration into diverse clinical environments. Explore the full suite of tools, including AccuLearning and Mozi TPS, for a comprehensive approach to radiation therapy planning and quality assurance.

ARTAssistant is built to be vendor-independent and fully interoperable, which should allow for smooth integration with various existing radiation oncology systems and workflows. This flexibility is a key advantage for clinics looking to adopt advanced AI tools without overhauling their entire infrastructure.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentSoftware
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

What the Web Says

ARTAssistant by Manteia Technologies is a software solution designed for radiation oncology, focusing on intelligent image analysis and processing for radiotherapy planning. It aims to enhance precision, efficiency, and automation in cancer treatment through AI and advanced algorithms. The software is vendor-independent and integrates into existing workflows, offering features like auto-contouring, plan review, and quality assurance.

Overall: Positive

Strengths

  • Enhances precision, efficiency, and automation in cancer treatment.
  • Vendor-independent and integrates into existing workflows.
  • Offers intelligent image analysis and processing for radiotherapy planning.
  • Includes features like auto-contouring, plan review, and QA.
  • AccuContour saves hundreds of hours for planners and maintains efficient workflow.
  • AccuLearning allows training standard models with custom data sets for personalized protocols.

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: G2.com, Capterra.com, parikhradiology.com, fda.report, klaritymedical.com, manteiamedical.com, medecine.ai, Reddit.com

Last updated: 2026-10-30

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ARTAssistant

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

meddevicestartups.com
ARTAssistant by Manteia Technologies cleared by FDA
ARTAssistant by Manteia Technologies Co., Ltd. received FDA 510(k) clearance (K250780) on December 5, 2025, for radiological image processing software.
2025-12
ramtechno.com
Medical Devices and Artificial Intelligence
ARTAssistant by Manteia Technologies is highlighted as a standalone software technology that enhances adaptive radiotherapy practices with AI, advanced algorithms, and big data.
2023-04
fda.gov
FDA 510(k) Premarket Notification for ARTAssistant
Manteia Technologies Co., Ltd. is listed as the applicant for ARTAssistant, a radiological image processing software, under FDA regulation number 892.205023.
2026-10
fda.gov
Radiological Image Processing Software for Radiation Therapy
ARTAssistant is identified as a Class 2 medical device, product code QKB, providing semi-automatic or fully-automated radiological image processing and analysis tools for radiation therapy using AI.
2026-10
medtekki.no
ARTAssistant on MedTekki
ARTAssistant by Manteia Technologies is listed on MedTekki, a platform for FDA-cleared, CE-marked, and EU AI-Act classified radiology AI medical devices.
unknown

Videos

Product demos, reviews, and walkthroughs for ARTAssistant.

Loading videos...

View all on YouTube

Frequently Asked Questions

ARTAssistant, an AI-powered tool, can assist oncologists in various ways, such as identifying targeted therapies based on a patient's genetic profile and helping to keep up with the rapidly evolving field of precision cancer therapy. It can also streamline workflows by automating tasks like documentation and treatment planning, and enhance clinical trial matching.
While AI tools like ARTAssistant offer significant potential, limitations include the risk of over-reliance on AI-generated outputs, potential for algorithmic bias if training data isn't diverse, and challenges in integrating with existing clinical workflows. AI models can also "hallucinate" or provide incorrect information, and their "black box" nature can make it difficult for clinicians to understand their decision-making processes.
For any AI tool handling patient data, HIPAA compliance is crucial. This typically involves robust data security measures, adherence to privacy rules, and proper handling of protected health information (PHI). ARTAssistant, like other virtual assistants, would need to have formal HIPAA training, sign Business Associate Agreements (BAAs), and utilize secure, encrypted systems for patient data to ensure compliance.
Yes, several AI tools are being developed and used in oncology. Examples include IBM Watson for Oncology, which provides decision support for personalized cancer treatment, and Tempus, which focuses on genomic data for targeted therapies. Other AI applications are also emerging for tasks like image recognition in tumor diagnosis and clinical trial matching.
Specific pricing for ARTAssistant is not publicly available. However, for similar AI-powered medical assistant services, pricing can vary significantly, ranging from hourly rates to per-FTE monthly bundles. These costs depend on factors such as the assistant's location and the services included.

Related Tools

SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
Paid
CerviCARE AI
NTL Healthcare
OB/GYN AI
CerviCARE AI is an AI-powered cervical cancer screening system that analyzes smartphone images of the cervix to predict findings, aiming for early detection.
Lumonus AI
Lumonus
Clinical Decision Support & Reference
Lumonus AI is an AI-powered software that assists healthcare providers with prescriptions, dosing, and treatment for cancer patients, with a module (Sigma) that suggests treatment protocols based on prior plans for similar patients.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.
Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.

See all Oncology AI tools →

More from Manteia Technologies Co.

AccuContour
Manteia Technologies Co., Ltd.
Oncology AI
AccuContour by Manteia Technologies is an AI-driven auto-contouring solution for radiation oncology, enhancing efficiency and precision in treatment planning through automated OAR and tumor target contouring, image fusion, plan review, and dose accumulation.
Contact for pricing
MOZI TPS
Manteia Technologies Co., Ltd.
Oncology AI
Mozi is the next-generation treatment planning solution, combining precision, speed, and adaptability. With built-in patient-specific goals, real-time adaptive planning, and intelligent automated planning, Mozi streamlines your workflow and evolves with future innovation.
Contact for pricing

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.